Literature DB >> 14511400

Detection of hypoxia in human brain tumor xenografts using a modified comet assay.

Jingli Wang1, Jack Klem, Jan B Wyrick, Tomoko Ozawa, Erin Cunningham, Jay Golinveaux, Max J Allen, Kathleen R Lamborn, Dennis F Deen.   

Abstract

We used the standard comet assay successfully to generate in vitro dose-response curves under oxic and hypoxic conditions. We then made mixtures of cells that had been irradiated with 3 and 9 Gy of X-rays to simulate two subpopulations in a tumor, but efforts to accurately detect and quantify the subpopulations using the standard comet assay were unsuccessful. Therefore, we investigated a modified comet assay to determine whether it could be used for measuring hypoxia in our model systems. U251 MG cells were grown as subcutaneous tumors in athymic mice; U251 MG and U87 MG cells were grown as intracerebral (i.c.) tumors in athymic rats. Animals were injected with RSU 1069, irradiated, and euthanized. Tumors and normal brains were removed, and the cells were analyzed using a modified comet assay. Differences in comet tail moment distributions between tumor and contralateral normal brain, using tail moments at either the 25th or 50th percentile in each distribution, were taken as measures of the degree of tumor hypoxia. For U251 MG tumors, there was a positive relationship between tumor size and the degree of hypoxia, whereas preliminary data from U87 MG i.c. tumors showed less hypoxia and no apparent relationship between tumor size and hypoxia.

Entities:  

Mesh:

Year:  2003        PMID: 14511400      PMCID: PMC1502416          DOI: 10.1016/S1476-5586(03)80022-2

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  19 in total

1.  The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy.

Authors:  L H GRAY; A D CONGER; M EBERT; S HORNSEY; O C SCOTT
Journal:  Br J Radiol       Date:  1953-12       Impact factor: 3.039

Review 2.  The comet assay: a comprehensive review.

Authors:  D W Fairbairn; P L Olive; K L O'Neill
Journal:  Mutat Res       Date:  1995-02       Impact factor: 2.433

3.  Growth of human glioblastomas as xenografts in the brains of athymic rats.

Authors:  Tomoko Ozawa; Jingli Wang; Lily J Hu; Andrew W Bollen; Kathleen R Lamborn; Dennis F Deen
Journal:  In Vivo       Date:  2002 Jan-Feb       Impact factor: 2.155

4.  Detection of hypoxic cells in a murine tumor with the use of the comet assay.

Authors:  P L Olive; R E Durand
Journal:  J Natl Cancer Inst       Date:  1992-05-06       Impact factor: 13.506

Review 5.  The unique physiology of solid tumors: opportunities (and problems) for cancer therapy.

Authors:  J M Brown; A J Giaccia
Journal:  Cancer Res       Date:  1998-04-01       Impact factor: 12.701

6.  Characterization of human glioblastoma xenograft growth in athymic mice.

Authors:  T Ozawa; J Wang; L J Hu; K R Lamborn; A W Bollen; D F Deen
Journal:  In Vivo       Date:  1998 Jul-Aug       Impact factor: 2.155

7.  Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma.

Authors:  D M Brizel; S P Scully; J M Harrelson; L J Layfield; J M Bean; L R Prosnitz; M W Dewhirst
Journal:  Cancer Res       Date:  1996-03-01       Impact factor: 12.701

8.  Microelectrophoretic study of radiation-induced DNA damages in individual mammalian cells.

Authors:  O Ostling; K J Johanson
Journal:  Biochem Biophys Res Commun       Date:  1984-08-30       Impact factor: 3.575

9.  Detection of hypoxic fractions in murine tumors by comet assay: comparison with other techniques.

Authors:  Q Hu; M C Kavanagh; D Newcombe; R P Hill
Journal:  Radiat Res       Date:  1995-12       Impact factor: 2.841

10.  Detection of hypoxia by measurement of DNA damage in individual cells from spheroids and murine tumours exposed to bioreductive drugs. II. RSU 1069.

Authors:  P L Olive
Journal:  Br J Cancer       Date:  1995-03       Impact factor: 7.640

View more
  6 in total

Review 1.  A review of the past, present, and future directions of neoplasia.

Authors:  Alnawaz Rehemtulla; Brian D Ross
Journal:  Neoplasia       Date:  2005-12       Impact factor: 5.715

2.  MicroRNA-378 enhances radiation response in ectopic and orthotopic implantation models of glioblastoma.

Authors:  Wende Li; Yujiao Liu; Weining Yang; Xiaoxing Han; Sen Li; Hao Liu; Leo E Gerweck; Dai Fukumura; Jay S Loeffler; Burton B Yang; Rakesh K Jain; Peigen Huang
Journal:  J Neurooncol       Date:  2017-10-28       Impact factor: 4.130

3.  Hyperpolarized 13C magnetic resonance metabolic imaging: application to brain tumors.

Authors:  Ilwoo Park; Peder E Z Larson; Matthew L Zierhut; Simon Hu; Robert Bok; Tomoko Ozawa; John Kurhanewicz; Daniel B Vigneron; Scott R Vandenberg; C David James; Sarah J Nelson
Journal:  Neuro Oncol       Date:  2010-01-25       Impact factor: 12.300

Review 4.  Brain tumors and epilepsy: pathophysiology of peritumoral changes.

Authors:  Mohammed F Shamji; Elana C Fric-Shamji; Brien G Benoit
Journal:  Neurosurg Rev       Date:  2009-02-11       Impact factor: 3.042

5.  Quantitative imaging of pO2 in orthotopic murine gliomas: hypoxia correlates with resistance to radiation.

Authors:  Hironobu Yasui; Tatsuya Kawai; Shingo Matsumoto; Keita Saito; Nallathamby Devasahayam; James B Mitchell; Kevin Camphausen; Osamu Inanami; Murali C Krishna
Journal:  Free Radic Res       Date:  2017-10

6.  Nomogram Predicting Overall Survival in Patients with FIGO II to III Squamous Cell Cervical Carcinoma Under Radical Radiotherapy: A Retrospective Analysis Based on 2018 FIGO Staging.

Authors:  Lele Zang; Qin Chen; Xiaozhen Zhang; Xiaohong Zhong; Jian Chen; Yi Fang; An Lin; Min Wang
Journal:  Cancer Manag Res       Date:  2021-12-29       Impact factor: 3.989

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.